MarketCap
Facebook
X
TelegramQuartalsbericht 2025-Q1
hinzugefügt 01.05.2025
Blueprint Medicines Corporation ROE 2011-2026 | BPMC
ROE Jährlich Blueprint Medicines Corporation
| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| -22.46 | -388.17 | -108.32 | -66.35 | 21.35 | -74.88 | -56.48 | -23.74 | -34.02 | -36.65 | - | - | - | - |
Alle Zahlen in USD-Währung
Indikatorenreichweite aus Jahresberichten
| Höchstwert | Mindestwert | Durchschnitt |
|---|---|---|
| 21.35 | -388.17 | -78.97 |
ROE Vierteljährlich Blueprint Medicines Corporation
| 2025-Q1 | 2024-Q4 | 2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| -51.41 | -4.89 | -70.89 | -118.91 | -145.98 | -139.95 | -160.74 | -115.55 | -94.22 | -54.18 | -63.58 | -52.18 | -38.99 | -24.68 | 18.44 | 70.97 | 70.73 | 27.18 | 12.89 | -50.53 | -63.6 | -74.88 | -79.76 | -76.81 | -61.8 | -56.48 | -45.16 | -33.85 | -32.75 | -23.74 | -25.86 | -27.72 | -31.23 | -34.02 | -34.86 | -35.74 | -35.89 | -36.65 | -7.61 | 14.4 | 33.86 | 50.75 | 32.52 | 19.29 | 8.85 | - | - | - | - | - | - | - | - | - | - | - | - |
Alle Zahlen in USD-Währung
Indikatorspanne aus vierteljährlicher Berichterstattung
| Höchstwert | Mindestwert | Durchschnitt |
|---|---|---|
| 70.97 | -160.74 | -36.56 |
ROE anderer Aktien in der Pharmaeinzelhändler
| Name | ROE | Preis | % 24h | Marktkapitalisierung | Land | |
|---|---|---|---|---|---|---|
 |
MorphoSys AG
MOR
|
15.76 | - | 2.43 % | $ 254 M |  Germany |
 |
Alterity Therapeutics Limited
ATHE
|
-36.22 | $ 3.33 | 0.91 % | $ 8.01 B |  Australia |
 |
ARCA biopharma
ABIO
|
-21.9 | - | 1052.0 % | $ 415 M |  USA |
 |
Aurinia Pharmaceuticals
AUPH
|
36.26 | $ 14.11 | -3.13 % | $ 1.9 B |  Canada |
 |
Aeterna Zentaris
AEZS
|
-401.79 | - | 5.93 % | $ 314 M | Canada |
 |
Albireo Pharma
ALBO
|
-19.38 | - | -0.23 % | $ 916 M | USA |
 |
I-Mab
IMAB
|
-85.31 | - | - | $ 866 M |  China |
 |
Alexion Pharmaceuticals, Inc.
ALXN
|
5.18 | - | - | $ 40.3 B | USA |
 |
Genfit SA
GNFT
|
626.29 | - | 2.54 % | $ 160 B |  France |
 |
Aileron Therapeutics
ALRN
|
-115.61 | - | 10.36 % | $ 9.8 M | USA |
 |
BioVie
BIVI
|
-92.27 | $ 1.29 | -3.31 % | $ 1.91 M | USA |
 |
Biophytis SA
BPTS
|
-751.94 | - | -13.47 % | $ 169 M | France |
 |
Ascendis Pharma A/S
ASND
|
-43.41 | $ 216.01 | -0.94 % | $ 5 B |  Danmark |
 |
BioNTech SE
BNTX
|
1.11 | $ 86.86 | -1.75 % | $ 27.2 B | Germany |
 |
Midatech Pharma plc
MTP
|
-330.29 | - | -18.52 % | $ 27.3 M |  Britain |
 |
EyeGate Pharmaceuticals, Inc.
EYEG
|
-115.61 | - | -1.52 % | $ 24.7 M | USA |
 |
Amphastar Pharmaceuticals
AMPH
|
12.44 | $ 19.42 | 0.99 % | $ 908 M | USA |
 |
Applied Genetic Technologies Corporation
AGTC
|
-62.37 | - | - | $ 26.5 M | USA |
 |
AgeX Therapeutics
AGE
|
-270.67 | - | -10.17 % | $ 12.2 K | USA |
 |
Acorda Therapeutics
ACOR
|
160.08 | - | -24.86 % | $ 820 K | USA |
 |
Corbus Pharmaceuticals Holdings
CRBP
|
-53.24 | $ 8.18 | -3.02 % | $ 109 M | USA |
 |
Acasti Pharma
ACST
|
-14.36 | - | 4.01 % | $ 150 M | Canada |
 |
CytomX Therapeutics
CTMX
|
-17.54 | $ 4.2 | -5.83 % | $ 579 M | USA |
 |
Институт стволовых клеток человека
ISKJ
|
17.55 | - | - | - |  Russia |
 |
CollPlant Biotechnologies Ltd.
CLGN
|
-123.35 | $ 0.73 | 20.26 % | $ 8.36 M |  Israel |
 |
Adverum Biotechnologies
ADVM
|
-185.15 | - | - | $ 86.2 M | USA |
 |
Acer Therapeutics
ACER
|
156.54 | - | 2.71 % | $ 14 M | USA |
 |
Advaxis
ADXS
|
196.88 | - | -9.65 % | $ 45.9 M | USA |
 |
Eton Pharmaceuticals
ETON
|
-17.59 | $ 22.9 | -3.82 % | $ 616 M | USA |
 |
Exelixis
EXEL
|
36.21 | $ 41.46 | 0.12 % | $ 11.3 B | USA |
 |
Avenue Therapeutics
ATXI
|
-418.16 | - | -52.27 % | $ 4.45 M | USA |
 |
Autolus Therapeutics plc
AUTL
|
-51.64 | $ 1.35 | -3.34 % | $ 344 M | Britain |
 |
Ayala Pharmaceuticals
AYLA
|
3458.87 | - | - | $ 7.46 M | Israel |
 |
ChemoCentryx
CCXI
|
-46.05 | - | - | $ 3.74 B | USA |
 |
Aytu BioScience
AYTU
|
-71.51 | $ 2.6 | -1.14 % | $ 16.3 M | USA |
 |
Fulcrum Therapeutics
FULC
|
-21.46 | $ 6.64 | -3.63 % | $ 421 K | USA |
 |
Atreca
BCEL
|
-123.92 | - | -11.76 % | $ 5.79 M | USA |
 |
BioDelivery Sciences International
BDSI
|
45.18 | - | -4.8 % | $ 255 M | USA |
 |
Genmab A/S
GMAB
|
24.88 | $ 25.62 | -0.23 % | $ 16.4 B | Danmark |
 |
Aeglea BioTherapeutics
AGLE
|
-21.7 | - | - | $ 1.01 B | USA |
 |
Grifols, S.A.
GRFS
|
9.2 | $ 7.6 | -1.24 % | $ 6.83 B |  Spain |
 |
CureVac N.V.
CVAC
|
-59.8 | - | - | $ 867 M | Germany |
 |
BeiGene, Ltd.
BGNE
|
6.58 | - | 0.49 % | $ 251 B |  Cayman-islands |
 |
Halozyme Therapeutics
HALO
|
649.18 | $ 61.92 | -1.5 % | $ 7.42 B | USA |
 |
Bellerophon Therapeutics
BLPH
|
-782.6 | - | -74.18 % | $ 955 K | USA |
 |
Akero Therapeutics
AKRO
|
-33.6 | - | - | $ 3.67 B | USA |
 |
Immatics N.V.
IMTX
|
1.79 | $ 9.4 | -1.16 % | $ 591 M | Germany |
 |
Arbutus Biopharma Corporation
ABUS
|
-43.75 | $ 4.29 | -2.94 % | $ 822 M | Canada |
 |
Incyte Corporation
INCY
|
24.9 | $ 90.93 | 0.53 % | $ 17.7 B | USA |
 |
Akouos
AKUS
|
-37.09 | - | 0.23 % | $ 488 M | USA |